EMA is hosting the 12th industry stakeholder platform on the operation of the centralised procedure for human medicines on 19 June ;

This will be the twelfth in a series of regular meetings between regulators and representatives of industry stakeholder organisations, aiming to foster a constructive exchange on general updates and more focused discussions on specific processes and issues to support continuous ;

This meeting will focus on: 

• updates on ongoing work on use of patient experience data and patient engagement in the centralised procedure; 
• digitalisation (PMS) and IRIS product life cycle management ;
• information on the initiative to increase the capacity of the EU medicines regulatory network (IncreaseNet); 
• lifecycle management of combination products at post-authorisation; 
• EMA's website; 
• submission preparedness on good manufacturing practice (GMP) aspects; 
• general update on procedural aspects on the centralised procedure; 
• EFPIA will also share results of an internal survey on selected aspects of the centralised procedure and other EMA ;